1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
QHSLab, Inc.

QHSLab, Inc.

USAQ
QHSLab, Inc.US flagOther OTC
0.28
USD
+0.05
- -
3.46MMarket Cap

Total Valuation

QHSLab, Inc. carries a market capitalization of 3.46M, placing it among publicly traded companies globally. Its enterprise value stands at 7.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.46M
Enterprise Value7.40M

Share Statistics

QHSLab, Inc. currently has 15.03M shares outstanding.

Shares Outstanding15.03M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

QHSLab, Inc. trades at a trailing price-to-earnings ratio of 17.84. The price-to-sales ratio is 2.78, and the price-to-book ratio stands at -1.93.

PE Ratio17.84
PS Ratio2.78
PB Ratio-1.93
P/TBV Ratio30.82
P/FCF Ratio341.99
P/OCF Ratio281.71

Enterprise Valuation

On an enterprise value basis, QHSLab, Inc. trades at an EV/EBITDA multiple of 61.16 and an EV/FCF ratio of 35.79. The EV/Sales ratio of 2.67 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 151.34 provides insight into valuation relative to core operating earnings.

EV / Sales2.67
EV / EBITDA61.16
EV / EBIT151.34
EV / FCF35.79

Financial Position

QHSLab, Inc. maintains a current ratio of 1.68, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.42, indicating elevated leverage, while an interest coverage ratio of 0.67 demonstrates limited ability to service its debt obligations.

Current Ratio1.68
Quick Ratio1.53
Debt / Equity2.42
Debt / EBITDA0.30
Interest Coverage0.67

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)24.35
Return on Invested Capital (ROIC)3.90
Return on Capital Employed (ROCE)-18.07
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover32.56

Stock Price Statistics

QHSLab, Inc.'s stock has gained approximately 56.66667% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 0.48.

Beta (5Y)N/A
52-Week Price Change56.66667%
50-Day Moving Average0.37
200-Day Moving Average0.48
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, QHSLab, Inc. generated 2.78M in revenue and converted that into 433,120.00 in net income, yielding earnings per share of 0.03. EBITDA reached 121,015.00, while operating income came in at 48,903.00.

Revenue2.78M
Gross Profit1.85M
Operating Income48,903.00
Pretax Income433,120.00
Net Income433,120.00
EBITDA121,015.00
EBIT48,903.00
Earnings Per Share (EPS)0.03

Balance Sheet

QHSLab, Inc. holds 362,088.00 in cash and equivalents against 36,877.00 in total debt, resulting in a net debt position of -325,211.00. Total book value stands at -4.01M, with working capital of 251,053.00 providing operational flexibility.

Cash & Cash Equivalents362,088.00
Total Debt36,877.00
Net Debt-325,211.00
Equity (Book Value)-4.01M
Book Value Per Share-0.32
Working Capital251,053.00

Cash Flow

QHSLab, Inc. produced 27,425.00 in operating cash flow over the past twelve months.

Operating Cash Flow27,425.00
Capital ExpendituresN/A
Free Cash Flow27,425.00
FCF Per Share0.00

Margins

QHSLab, Inc. operates with a gross margin of 66.73, reflecting its pricing power and cost economics. The operating margin of 1.76 and net profit margin of 15.61 provide insight into operational efficiency.

Gross Margin66.73
Operating Margin1.76
Pretax Margin15.61
Profit Margin15.61
EBITDA Margin4.36

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-3.54
FCF Yield0.29

Stock Splits

QHSLab, Inc.'s most recent stock split took place on May 7, 2010 with a 200:1 split ratio.

Last Split Date5/7/2010
Split Ratio200:1

Scores

QHSLab, Inc. posts an Altman Z-Score of 8.76, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score8.76